Jane Street’s Veracyte VCYT Stock Holding History

Jane Street’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$599K	Buy	13,000 +200	+2%	+$9.6K	﹤0.01%	7605
2026 Q2	$752K	Sell	12,800 -600	-4%	-$25.2K	﹤0.01%	7145
2026 Q1	$432K	Buy	+13,400	New	+$496K	﹤0.01%	8395
2022 Q2	–	Sell	-20,000	Closed	-$551K	–	10975
2022 Q1	$551K	Buy	20,000 +15,000	+300%	+$429K	﹤0.01%	7286
2021 Q4	$206K	Buy	+5,000	New	+$221K	﹤0.01%	8783

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jane Street's VCYT Position: Q3 2026 in Review

Jane Street sold out of Veracyte (VCYT) in Q3 2026, closing a stake of 4,381 shares — an estimated $211K sold.

Jane Street first reported a position in VCYT in Q4 2018 and held it in 21 quarters. The position peaked at $10.3M in Q3 2024. 271 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

Jane Street reported no remaining Veracyte position as of Q3 2026 after selling out during the quarter.
Jane Street sold 4,381 Veracyte shares in Q3 2026, an estimated $211K.
Jane Street first reported a position in Veracyte in Q4 2018 and held it in 21 quarters.
Jane Street's Veracyte position peaked at $10.3M in Q3 2024.
271 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.